The start-up will launch a cycle-synced lifestyle app to help women manage their hormonal health
Endometrial cancer is the most commonly diagnosed gynaecologic cancer in American women
The app has benefitted from a complete redesign and redevelopment to provide clear visual learning for latching
Second novel PCOS drug target from Celmatix-Evotec Alliance progresses into hit-identification
The developers believe the test will help drive the development of new therapeutics for endometriosis
The round brings the company's total funding to US$22.3m, underscoring the need to rebuild US maternity care services
Phexxi will be the first and only hormone-free contraceptive offered by Favor
The clinic has previously raised €17m in funding to expand to Spain, Germany and Italy
Following the Supreme Court's decision to end the right to abortion, US care providers had to find new ways to deliver critical services
The designation seeks to streamline the development of new agents with potential to treat serious or life-threatening diseases
